NCT04953247View on ClinicalTrials.gov

Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

February 7, 2020

Primary Completion Date

February 17, 2020

Study Completion Date

June 20, 2021

Conditions
COVID-19 PneumoniaQuantitative Computed Tomography
Trial Locations (1)

Unknown

Zhongshan hospital, Fudan university, Shanghai

All Listed Sponsors
lead

Guowei Tu

OTHER

NCT04953247 - Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19 | Biotech Hunter | Biotech Hunter